Cipla Health Limited v. Aristo Pharmaceuticals Pvt. Ltd. & Anr.
Case brief
What is this about?
Trade mark dispute between Cipla Health and Aristo Pharmaceuticals over OLYTE/ARISTOOLYTE marks settled amicably. Defendants agreed to discontinue use of the disputed mark, cancel registrations, and destroy cartons. Suit decreed in terms of settlement; 75% court fee refund granted.